Yes, insomnia is a well-established side effect of Wellbutrin (bupropion).
Insomnia is one of the most common adverse effects of bupropion, occurring significantly more frequently than with placebo, and is explicitly documented in FDA labeling and clinical guidelines. 1
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for Wellbutrin clearly identifies insomnia as a frequent adverse reaction:
- In major depressive disorder trials with bupropion sustained-release, insomnia occurred at rates requiring specific mention in dosing recommendations 1
- In seasonal affective disorder trials, insomnia occurred in 20% of patients on Wellbutrin XL versus 13% on placebo, and was the leading cause of treatment discontinuation (2% vs <1%) 1
- The FDA label specifically warns: "to minimize risk of insomnia, give second dose before 3 p.m." for twice-daily formulations 2
Clinical Trial Data
Multiple controlled trials consistently demonstrate bupropion's association with insomnia:
- Bupropion showed the highest incidence of insomnia among second-generation antidepressants in meta-analysis 3
- In smoking cessation trials, insomnia was reported in 40% of patients taking bupropion SR 300 mg/day, significantly higher than placebo 4
- The effect is dose-related, with higher rates at 400 mg/day versus 300 mg/day 1
Mechanism and Clinical Context
Bupropion's activating properties stem from its mechanism as a norepinephrine-dopamine reuptake inhibitor (NDRI), which increases alertness and arousal 5, 6. This distinguishes it from sedating antidepressants like mirtazapine or trazodone.
Clinical guidelines for insomnia management specifically list bupropion among antidepressants that can contribute to insomnia 7, recommending it be avoided in agitated patients 2.
Practical Management Strategies
When prescribing bupropion:
- Administer the second daily dose before 3 p.m. to minimize sleep disruption 2, 8
- Consider once-daily XL formulation taken in the morning to reduce evening stimulation
- Start with lower doses (150 mg/day) and titrate gradually, as insomnia is dose-dependent 1
- Monitor within 1-2 weeks of initiation, as insomnia typically emerges early in treatment 9
- If insomnia persists and is clinically significant, consider switching to a more sedating antidepressant (mirtazapine, trazodone) rather than adding hypnotics 7
Important Caveats
While insomnia is common with bupropion, recent comparative effectiveness data suggest that bupropion specifically improves hypersomnia, increased appetite, and fatigue better than other antidepressants 10. Therefore, bupropion may be the preferred choice for patients with depression characterized by hypersomnia and low energy, where its activating properties become therapeutic rather than problematic.
The insomnia side effect should be weighed against bupropion's advantages: lower rates of sexual dysfunction, weight gain, and somnolence compared to SSRIs 6, making it particularly suitable for patients concerned about these alternative side effects.